Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion type Assertion NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_head.
- NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_provenance.
- NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion evidence source_evidence_literature NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_provenance.
- NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion SIO_000772 21833654 NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_provenance.
- NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion wasDerivedFrom befree-2016 NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_provenance.
- NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion wasGeneratedBy ECO_0000203 NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_provenance.